Tiziana Bruno

Tiziana Bruno

Auto-generated profile, based on publicly available information

Tiziana Bruno

Microbiology and Virology Unit, San Gallicano Dermatological Institute IRCCS

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 December 2025 in Blood
Verified
Journal Article
Open access
TBTiziana Bruno
Tiziana Bruno
MCMaria Chiara Cappelletto
Maria Chiara Cappelletto
CCClelia Cortile
Clelia Cortile
SGStefano Di Giovenale
Stefano Di Giovenale
BABruno Amadio
Bruno Amadio
GCGiacomo Corleone
Giacomo Corleone
Multiple myeloma (MM) continues to be an incurable malignancy, even with recent therapeutic advancements. Although epigenetic dysregulation at cis-regulatory elements is known to drive disease progression, the complete molecular mechanisms underlying these alterations are poorly understood. Using Assay for Transposase-Accessible Chromatin with high-throughput sequencing analysis combined with the computational footprinting of CD138+ cells from 55 patients with MM, we depicted the dynamic changes in chromatin accessibility during disease progression and identified nuclear respiratory factor 1 (NRF1) as a master regulator of vital MM survival pathways. We demonstrated that NRF1 maintains proteasome homeostasis by orchestrating the ubiquitination pathway, which is essential for MM cell survival. We discovered a novel enhancer element that physically interacts with the NRF1 promoter, sustaining its expression. Targeting this enhancer RNA reduced NRF1 levels and increased tumor cell sensitivity to bortezomib (BTZ), suggesting therapeutic potential. In xenograft models, we showed that antisense oligonucleotides targeting the NRF1 enhancer, either alone or combined with BTZ, significantly decreased tumor burden and improved survival. Our findings reveal a previously unknown NRF1-dependent mechanism regulating MM cell survival and present a promising therapeutic approach through the manipulation of its regulatory network.

26 August 2026 in Epigenetics Reports
Verified
Journal Article
Open access
MCMaria Chiara Cappelletto
Maria Chiara Cappelletto
GCGiacomo Corleone
Giacomo Corleone
FNFrancesca De Nicola
Francesca De Nicola
TBTiziana Bruno
Tiziana Bruno
Dysregulation of epigenetic and genetic mechanisms driving malignant transformation is a hallmark of cancer [1]. In multiple myeloma (MM), a plasma cell malignancy characterized by clonal expansion...